Role of 5-ht7 receptors in the long-lasting hypotensive response induced by 5-hydroxytryptamine in the rat

British Journal of Pharmacology

Volumn 121, Issue 3, 1997, Pages 563-571

  Terrón, José A ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

5 hydroxytryptamine; Hypotension; Vascular 5 ht7 receptors

Indexed keywords

5 CARBAMOYLTRYPTAMINE; 5 METHOXYTRYPTAMINE; BEMESETRON; CLOZAPINE; INDOMETACIN; KETANSERIN; LISURIDE; MESULERGINE; METERGOLINE; METHOXAMINE; METHYSERGIDE; METITEPINE; MIANSERIN; N(G) NITROARGININE METHYL ESTER; NEUROLEPTIC AGENT; NITRIC OXIDE SYNTHASE INHIBITOR; PROPRANOLOL; PROSTAGLANDIN SYNTHASE INHIBITOR; RECEPTOR SUBTYPE; RISPERIDONE; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 4 ANTAGONIST; SEROTONIN 4 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SUMATRIPTAN; 5-CARBOXAMIDOTRYPTAMINE; DRUG DERIVATIVE; SEROTONIN 7 RECEPTOR;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BLOCKING; ANIMAL; BLOOD PRESSURE; DRUG EFFECT; PHYSIOLOGY; WISTAR RAT;

ANIMALS; BLOOD PRESSURE; INDOMETHACIN; MALE; NG-NITROARGININE METHYL ESTER; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0030610298     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701134     Document Type: Article

References (62)

1. 1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc. Natl. Acad. Sci. U.S.A., 90, 408-412.
2. 1E-like' serotonin receptor expressed pedominantly in hippocampus. J. Biol. Chem., 267, 19761-19764.
3. BALASUBRAMANIAM, G., LEE, H.S. & MAH, S.C. (1993). Anti-hypertensive effect of chronic i.v. administration of 5-carboxamidotryptamine in spontaneously hypertensive rats. Eur. J. Pharmacol., 237, 207-213.
4. 7) positively linked to adenylate cyclase. J. Biol. Chem., 268, 23422-23426.
5. 2 receptor subtypes: a family re-united? Trends Pharmacol. Sci., 16, 105-110.
6. BRADLEY, P.B., ENGEL, G., FENIUK, W., FOZARD, J.R, HUMPHREY, P.P A., MIDDLEMISS, D.N., MYLECHARANE, E.J., RICHARDSON, B.P. & SAXENA, P.R. (1986). Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology, 25, 563-576.
7. 4 receptor antagonists, GR113808 and GR125487. Proceedings of the Third IUPHAR Satellite Meeting on Serotonin, Chicago, July 30-August 3, 1994. p. 33. Symposium 15.
8. CARTER, D., CHAMPNEY, M., HWANG, B. & EGLEN, R.M. (1995). Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea-pig isolated ileum. Eur. J. Pharmacol., 280, 243-250.
9. 2 receptors: Implications for drug mechanisms of action. Life sci., 39, 2571-2586.
10. 7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery. J. Pharmacol. Exp. Ther., 211, 1560-1566.
11. 1-like receptors. In The Cardiovascular Pharmacology of 5-Hydroxytryptamine: Prospective Therapeutic Applications, ed. Saxena P.R., Wallis, D.I., Wouters, W. & Bevan P., pp. 285-294. Dordrecht: Kluwer Academic Publishers.
12. FENIUK, W., HUMPHREY, P.P.A. & WATTS, A.D. (1983). 5-Hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle. Eur. J. Pharmacol., 96, 71-78.
13. FOZARD, J.R. (1984). MDL 72222: a potent and highly selective antagonist at neuronal 5-HT receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 326, 36-44.
14. FOZARD, J.R., MIR, A.K. & MIDDLEMISS, D.N. (1987). Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis. J. Cardiovasc. Pharmacol., 9, 328-347.
15. GOTHERT, M., SCHLICKER, E. & KOLLECKER, P. (1986). Receptor-mediated effects of serotonin and 5-methoxytryptamine on noradrenaline release in rat vena cava and in the heart of the pithed rat. Naunyn-Schmiedeberg's Arch. Pharmacol., 332, 124-130.
16. GRADIN, K., PETTERSON, A., HEDNER, T. & PERSSON, B. (1985). Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat. J. Neural Trans., 62, 305-319.
17. 1D receptor subtypes. Trends Pharmacol. Sci., 17, 103-105.
18. HOUSTON, D.S. & VANHOUTTE, P.M. (1988). Comparison of serotonergic receptor subtypes on the smooth muscle and endothelium of the canine coronary artery. J. Pharmacol. Exp. Ther., 244, 1-10.
19. 1 recognition sites. J. Recept. Res., 8, 59-81.
20. HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.P.A. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157-203.
21. 1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus. A pharmacological characterization. Naunyn-Schmiedeherg's Arch. Pharmacol., 339, 252-258.
22. 1-like receptor in dog isolated saphenous vein. Br. J. Pharmacol., 94, 1123-1132.
23. KALKMAN, H.O., TIMMERMANS, P.B.M.W.M. & VAN ZWIETEN, P.A. (1982). Characterization of the antihypertensive properties of ketanserin (R41468) in rats. J. Pharmacol. Exp. Ther., 222, 227-231.
24. 1 receptors. Eur. J. Pharmacol., 91, 155-156.
25. KAEKMAN, H.O., ENGEL, G. & HOYER, D. (1984). Three distinct types of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats. J. Hypertens. (Suppl. 2), 6, S421-S428.
26. 125I]LSD binding. Eur. J. Pharmacol., 129, 139-145.
27. LEFF, P., MARTIN, G.R. & MORSE, J.M. (1987). Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues. Br. J. Pharmacol. 91, 321-331.
28. LEYSEN, J.E. (1985). Serotonin binding sites. In Serotonin and the Cardiovascular System. ed. Vanhoutte, P.M. pp. 43-62. New York: Raven Press.
29. EEYSEN, J.E., GOMMEREN, W., EENS, A., DE CHAFFOY DE COURCELLES, D., STOOF, J.C. & JANSSEN, P.A.J. (1988). Biochemical profile of risperidone, a new antipsychotic. J. Pharmacol. Exp. Ther., 247, 661-670.
30. 7) implicated in the regulation of mammalian circadian rhythms. Neuron, 11, 449-458.
31. MARTIN, G.F. (1994). Vascular receptors for 5-hydroxytryptamine: distribution, function and classification. Pharmacol. Ther., 62, 283-324.
32. MARTIN, G.R., LEFF, P., CAMBRIDGE, D. & BARRETT, V.J. (1987). Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines. Naunyn Schmiedeberg's Arch. Pharmacol., 336, 365-373.
33. 7 receptor? Br. J. Pharmacol., 114, 383P.
34. 1-like subtype. Proc. Natl. Acad. Sci. U.S.A., 89, 5517-5521.
35. i values. J. Pharmacol. Exp. Ther., 251, 238-246.
36. MONSMA, F.J., SHEN, Y., WARD, R.P., HAMBLIN, M.W. & SIBLEY, D.R. (1993). Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol., 43, 320-327.
37. PAGE, I.H. (1957). Cardiovascular actions of serotonin (5-hydroxytryptamine). In 5-Hydroxytryptamine. ed. Lewis, G.P. pp. 93-108. London: Pergamon.
38. PAGE, L.H. & MCCUBBIN, J.W. (1953). Modification of vascular responses to serotonin. Am. J. Physiol., 174, 436-440.
39. 1D binding sites. Eur. J. Pharmacol., 163, 133-136.
40. PLASSAT, J.L., AMLAIKY, N. & HEN, R. (1993). Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol. Pharmacol., 44, 229-236.
41. G-nitro-L-arginine as affected by blockade of pressor mechanisms mediated by the sympathetic nervous system, angiotensin, prostanoids and vasopressin. J. Pharmacol. Exp. Ther., 261, 240-245.
42. 1C receptors. J. Pharmacol. Exp. Ther., 260, 1361-1365.
43. ROTH, B.L., CRAIGO, S.C., CHOUDHARY, M.S., ULUER, A., MONSMA, F.J., SHEN, Y., MELTZER, H.Y. & SIBLEY, D.R. (1994). Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther., 268, 1403-1410.
44. 1C mRNA and receptor levels. Dev. Brain Res., 58, 51-58.
45. 7) activating cAMP formation. Proc. Natl. Acad. Sci. U.S.A., 90, 8547-8551.
46. SAXENA, P.R. (1995). Serotonin receptors: Subtypes, functional responses and therapeutic relevance. Pharmacol. Ther., 66, 339-368.
47. 1 receptors. Arch. In. Pharmacodyn. Ther., 277, 235-252.
48. SCHOTTE, A., JANSSEN, P.F.M., GOMMEREN, W., LUYTEN, W.H.M.L., VAN GOMPEL, P., LESAGE, A.S., DE LOORE, K. & LEYSEN, J.E. (1996). Risperidone compared with new and reference antipyschotic drugs: in vitro and in vivo receptor binding. Psychopharmacology, 124, 57-73.
49. 7 serotonin receptor subtype. J. Biol. Chem., 268, 18200-18204.
50. SHIPLEY, R.E. & TILDEN, J.H. (1947). A pithed rat preparation suitable for assaying pressor substances. Proc. Soc. Exp. Biol. Med., 64, 453-455.
51. STEEL, R.G.D. & TORRIE, J.H. (1980). Principles and Procedures of Statistics, A Biomedical Approach, 2nd edn. Tokyo: McGraw-Hill Kogakusha, Ltd.
52. SUMNER, M.J., FENIUK, W. & HUMPHREY, P.P.A. (1989). Further characterization of the 5-HT receptor mediating vascular relaxation and elevation of cyclic AMP in porcine isolated vena cava. Br. J. Pharmacol., 97, 292-300.
53. 1 receptor-induced smooth muscle contraction in dog saphenous vein. Br. J. Pharmacol., 105, 603-608.
54. SUMNER, M.J. & HUMPHREY, P.P.A. (1990). Sumatriptan (GR43175) inhibits cyclic-AMP accumulation in dog isolated saphenous vein. Br. J. Pharmacol., 99, 219-220.
55. 7 receptor subtype. Br. J. Pharmacol., 118, 1421-1428.
56. TERRON, J.A. (1996b). Typical and atypical antipsychotic drugs are potent antagonists of the relaxant 5-hydroxytryptamine receptor in the smooth muscle of canine coronary artery. Proc. West. Pharmacol. Soc., 39, 23-25.
57. TREVETHICK, M.A., FENIUK, W. & HUMPHREY, P.P.A. (1984). 5-Hydroxytryptamine-induced relaxation of neonatal porcine vena cava in vitro. Life Sci., 35, 477-486.
58. TREVETHICK, M.A., FENIUK, W. & HUMPHREY, P.P.A. (1986). 5-Carboxamidotryptamine: a potent agonist mediating relaxation and elevation of cyclic AMP in the isolated neonatal porcine vena cava. Life. Sci., 38, 1521-1528.
59. 7 receptors in guinea-pig brain. Br. J. Pharmacol., 115, 107-116.
60. VAN WIJNGAARDEN, I., TULP, M.Th.M. & SOUDIJN, W. (1990). The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol., 188, 301-312.
61. G-nitro-L-arginine methyl ester in vitro and in vivo. J. Pharmacol. Exp. Ther., 267, 1091-1099.
62. ZGOMBICK, J.M., SCHECHTER, L.E., MACCHI, M., HARTIG, P.R., BRANCHEK, T.A. & WEINSHANK, R.L. (1992). Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptaminejg receptor. Mol. Pharmacol., 42, 180-185.